Showing posts with label chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Show all posts
Showing posts with label chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Show all posts
Tuesday, July 23, 2013

New Drug Application Submitted to U.S. FDA for Ibrutinib in the Treatment of Two B-Cell Malignancies

›
We know that,  Ibrutinib , also known as PCI-32765, is an experimental drug candidate for the treatment of various types of cancer. It is...